News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|May 1, 2003

A refreshing way to distinguish allergy from infection?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

ByMorgan Ebert, Executive Editor

June 23rd 2026

FDA approves generic baloxavir marboxil for flu treatment, prophylaxis

ByBenjamin P. Saylor

June 18th 2026

FDA clears Capvaxive as supplemental PCV for at-risk children

ByBenjamin P. Saylor

June 18th 2026

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure | Image Credit: © Zerbor - stock.adobe.com

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

ByMorgan Ebert, Executive Editor

June 12th 2026

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

ByMorgan Ebert, Executive Editor

June 10th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Keeping kids safe this 4th of July: What families should know about fireworks

Top 5 pediatric health headlines you missed in June 2026

FDA news in pediatrics: June 2026

Keeping it safe: Food tips for picnics, cookouts and beach days

New button battery technology could strengthen injury prevention efforts, with Kris R. Jatana, MD